Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Shoji

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Journal of Cardiac Failure|November 10, 2025
Clinical Outcomes and Health Care Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HFSatoshi Shoji, Uchechukwu Ikeaba, Gregg C Fonarow, et al.
BMC Cancer|December 4, 2019
Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational studySatoshi Shoji, Michihiro Hosojima, Hideyuki Kabasawa, et al.
European Journal of Heart Failure|October 13, 2025
Physician-reported reasons for not prescribing guideline-directed medical therapy in heart failure with reduced ejection fraction: A prospective registry analysisYumiko Kawakubo Ichihara, Yasuyuki Shiraishi, Mitsuaki Sawano, et al.
The American Journal of Cardiology|July 22, 2025
Sex Differences in Safety and Efficacy of Dual Antiplatelet Therapy Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsTetsuya Saito, Yoshihisa Miyamoto, Tomohiro Fujisaki, et al.
BMC Cancer|March 17, 2016
Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factorsKo Sato, Satoshi Watanabe, Aya Ohtsubo, et al.
Plos One|April 13, 2019
Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutationsMiyuki Sato, Satoshi Watanabe, Hiroshi Tanaka, et al.
Journal of the American Heart Association|August 23, 2025
Ticagrelor Paradox: Systematic Review and Network Meta-AnalysisAtsuyuki Watanabe, Tadao Aikawa, Yoshihisa Miyamoto, et al.
American Heart Journal|November 6, 2024
Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HFSatoshi Shoji, Derek D Cyr, Adrian F Hernandez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2025
Revised definition of pulmonary hypertension subtypes enhances prognostic stratification in hospitalized heart failure patientsKei Fukushi, Ayumi Goda, Takashi Kohno, et al.
JACC. Clinical Electrophysiology|July 27, 2023
Baseline Health Status and its Association With Subsequent Cardiovascular Events in Patients With Atrial FibrillationNobuhiro Ikemura, John A Spertus, Dan D Nguyen, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Journal of Cardiac Failure|November 10, 2025
Clinical Outcomes and Health Care Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HFSatoshi Shoji, Uchechukwu Ikeaba, Gregg C Fonarow, et al.
BMC Cancer|December 4, 2019
Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational studySatoshi Shoji, Michihiro Hosojima, Hideyuki Kabasawa, et al.
European Journal of Heart Failure|October 13, 2025
Physician-reported reasons for not prescribing guideline-directed medical therapy in heart failure with reduced ejection fraction: A prospective registry analysisYumiko Kawakubo Ichihara, Yasuyuki Shiraishi, Mitsuaki Sawano, et al.
The American Journal of Cardiology|July 22, 2025
Sex Differences in Safety and Efficacy of Dual Antiplatelet Therapy Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsTetsuya Saito, Yoshihisa Miyamoto, Tomohiro Fujisaki, et al.
BMC Cancer|March 17, 2016
Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factorsKo Sato, Satoshi Watanabe, Aya Ohtsubo, et al.
Plos One|April 13, 2019
Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutationsMiyuki Sato, Satoshi Watanabe, Hiroshi Tanaka, et al.
Journal of the American Heart Association|August 23, 2025
Ticagrelor Paradox: Systematic Review and Network Meta-AnalysisAtsuyuki Watanabe, Tadao Aikawa, Yoshihisa Miyamoto, et al.
American Heart Journal|November 6, 2024
Win Ratio Analyses Using a Modified Hierarchical Composite Outcome: Insights From PARAGLIDE-HFSatoshi Shoji, Derek D Cyr, Adrian F Hernandez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2025
Revised definition of pulmonary hypertension subtypes enhances prognostic stratification in hospitalized heart failure patientsKei Fukushi, Ayumi Goda, Takashi Kohno, et al.
JACC. Clinical Electrophysiology|July 27, 2023
Baseline Health Status and its Association With Subsequent Cardiovascular Events in Patients With Atrial FibrillationNobuhiro Ikemura, John A Spertus, Dan D Nguyen, et al.
Pageof 11